2 stories mentioning TYO:4887Updated just now
Every FINWIRES story that references TYO:4887, newest first.
Sawai Group (TYO:4887) approved the issuance of 30,789 new common shares worth about 51 million yen under its restricted share and performance-linked restricted share compensation plans.The shares will be issued at 1,658 yen each to directors, officers and directors of group companies under the company's equity-based compensation programs, according to a company filing on Thursday.
Sawai Group (TYO:4887) has approved the transfer of its digital therapeutics business for non-alcoholic steatohepatitis (NASH) to wholly owned subsidiary Sawai Pharmaceutical through an absorption-type company split.The transfer is scheduled to take effect on Sept. 1, according to a company filing on Thursday. Sawai Pharmaceutical will assume the assets, liabilities, contracts and other rights and obligations related to the NASH digital therapeutics business.The move is intended to streamline Sawai Group's commercialization efforts by placing the business under its core pharmaceutical subsidiary.
